NCT02191540 - Efficacy and Safety Study of Abnoba Viscum F 20mg in Malignant Pleural Effusion Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

January 31, 2013

Study Completion Date

May 31, 2013

Conditions

Malignant Pleural Effusion

Interventions

DRUG

Abnoba Viscum F 20mg

intravesical instillation of five amples of AbnobaViscum® F20mg and 0.9% normal saline into the pleural space

Trial Locations (3)

Busan University Hospital, Busan

Chonnam National University Hwasun hospital, Hwasun Gun

Ulsan University Hospital, Ulsan